Abstract: The present invention provides a prophylactic and/or therapeutic agent for ALS containing a Src/c-Abl pathway inhibitor.

Abstract: The present invention provides a method for expanding PGC/PGCLC, including culturing PGC/PGCLC in the presence of a phosphodiesterase 4 (PDE4) inhibitor and/or cyclosporine A, further in the presence of forskolin, and a method for inducing oocytes from PGC/PGCLC, including culturing PGC/PGCLC in the presence of bone forming protein (BMP) and retinoic acid (RA).

Abstract: A bioparticle observation apparatus includes a dielectrophoresis electrode that outputs a first signal causing a dielectrophoresis force to act on a bioparticle, a sensor electrode that detects an impedance difference between the bioparticle and the liquid, and a control circuit that controls the first signal so that the detected impedance difference is fixed.

Abstract: Provided are a method for producing a multibranched polymer that can produce a multibranched polymer having a narrow molecular weight distribution in a one-pot procedure and the multibranched polymer. A method for producing a multibranched polymer includes the step of polymerizing a first vinyl monomer having a polymerization-initiating group in an ?-position of a vinyl bond and a second vinyl monomer free of polymerization-initiating group in an ?-position of a vinyl bond by a living radical polymerization.

Abstract: The present invention provides an actuator-equipped knee ankle foot orthosis in which a control device calculates a thigh phase angle based on an angle-related signal detected by a thigh orientation detecting means at one sampling point, applies the thigh phase angle at that sampling point to an assisting force control data, which is stored in the control device in advance and indicates the relationship between the thigh phase angle and a size of the assisting force to be imparted to a lower leg-side brace, to obtain the size of the assisting force to be imparted to the lower leg-side brace at that sampling point, and executes operational control for an actuator unit such that the assisting force having the size is output.

Abstract: An IC tag reading device is provided that has increased directivity and is capable of determining an accurate position of an IC tag inserted into and placed in a human body even when the operation range of the antenna of the reading device is limited, such as in thoracoscopy, without causing reduction in detectable distance. A reading device antenna for reading an IC tag that has been inserted into a human body and placed at a certain position in order to locate a lesion includes a coil portion having a coil with a predetermined number of turns in a circumferential direction, and a shield portion that covers at least an approximately half of the coil portion in the circumferential direction and causes a bias in a magnetic flux generated from the coil.

Abstract: A structure evaluation apparatus has an acquisitor and an evaluator. The acquisitor acquires a distribution that represents a distribution of strength of a reflected wave obtained by an electromagnetic radar scan to a reinforced concrete which comprises concrete and a material other than concrete. The evaluator calculates similarity, with reference to a reference region including the material in the distribution, of other regions including the material than the reference region in the distribution.

Abstract: A liquid injection method for injecting a liquid into a culture vessel includes tilting the culture vessel around a horizontal axis at a tilt angle (X°) of greater than 0° and 50° or less, wherein adherent cells are adhered to the culture vessel; and injecting the liquid into the culture vessel at a predetermined linear velocity (Y mm/s) via a wall surface of the culture vessel tilted at the tilt angle (X°), wherein the tilt angle (X) and the linear velocity (Y) satisfy the following (formula 1): Y?5.075X+123 (formula 1).

Abstract: A propagation channel estimation method is provided. In-phase and quadrature components of a propagation channel estimation value in each pilot subcarrier are separated into amplitude and phase components. A propagation channel of a data subcarrier portion existing between pilot subcarriers is estimated by phase/amplitude separation linear interpolating in each separated amplitude and phase component. A reference parameter is produced by linear interpolating a portion between pilot subcarriers on a complex plane. When quadrants on the complex plane of the interpolated phase component estimation value and the reference parameter are different, a phase connecting process to cancel a discontinuity of the phases is executed to the phase component estimation value interpolated by the phase/amplitude separation linear interpolation.

Abstract: An object of the present invention is to provide a composition for preventing or improving fat deposition on the liver in spite of the alcohol intake history of a level that a liver disease is not caused. The inventors found that glutathione has an effect of preventing or improving fat deposition on the liver, which is not caused by alcohol, and completed the present invention. Among nonalcoholic fat diseases, the present invention is particularly effective in an early stage of the treatment or in a case where treatment for another disease is not performed.

Abstract: Provided is a method for separating the four optical isomers of Nahlsgen.

Abstract: A thermal radiation light source includes a laminated body including m quantum layers laminated where m is an integer of 2 or more, including an n-layer and a p-layer sandwiching the quantum layers from both sides in the laminating direction, the n-layer made of an n-type semiconductor and the p-layer made of a p-type semiconductor; a voltage applying unit for the m quantum layers is directly or indirectly connected to the n-layer and p-layer sandwiching each layer applying a voltage for moving to the n-layers or p-layers a charge; a voltage switching unit switches ON/OFF of application of the voltage to the m quantum layers; and a photonic crystal portion disposed in the laminated body or adjacent to the laminated body, so that lights of m wavelengths resonate, the lights of the m wavelengths generated in the m quantum layers corresponding to transition energy between subbands in the quantum layer.

Abstract: New use of ADAMTS13 in the clinical filed is provided. The use of ADAMTS13 as a biomarker for monitoring the onset of liver damage, hepatic ischemia/reperfusion injury or the liver function after liver transplantation: a method of testing liver damage, a method of testing hepatic ischemia/reperfusion injury, or a method of testing the liver function after liver transplantation, each of the methods comprising measuring or monitoring the ADAMTS13 activity in a sample from a mammal; an agent for treating diseases selected from the group consisting of liver damage, hepatic ischemia/reperfusion injury and hepatic dysfunction after liver transplantation, which comprises ADAMTS13 or a mutant of ADAMTS13 as an effective ingredient.

Abstract: The present disclosure provides a novel aldehyde synthase gene having activity of synthesizing a medium-chain aldehyde. Such gene encodes a protein comprising the amino acid sequence as shown in SEQ ID NO: 2.

Abstract: The object of the present invention is to provide an electrolyte for a fluoride ion battery with high activity for fluoridating an active material. The present invention solves the problem by providing an electrolyte for a fluoride ion battery comprising a fluoride complex salt as at least one of LiPF6 and LiBF4, and an organic solvent; and B/A is 0.125 or more in the case where a substance amount of the organic solvent is regarded as A (mol) and a substance amount of the fluoride complex salt is regarded as B (mol).

Abstract: A propagation channel estimation method is provided. In-phase and quadrature components of a propagation channel estimation value in each pilot subcarrier are separated into amplitude and phase components. A propagation channel of a data subcarrier portion existing between pilot subcarriers is estimated by phase/amplitude separation linear interpolating in each separated amplitude and phase component. A reference parameter is produced by linear interpolating a portion between pilot subcarriers on a complex plane. When quadrants on the complex plane of the interpolated phase component estimation value and the reference parameter are different, a phase connecting process to cancel a discontinuity of the phases is executed to the phase component estimation value interpolated by the phase/amplitude separation linear interpolation.

Abstract: An induction heating device includes: a rotor having a rotation shaft; a heating part disposed to be opposed to the rotor at a distance; a magnetic flux generating part provided at the rotor to generate magnetic flux for the heating part; a magnetic flux guide part provided on an opposed surface side of the heating part that is opposed to the magnetic flux generating part to guide the magnetic flux from the magnetic flux generating part to the heating part; and a flow passage provided in the heating part to allow a heating medium to circulate. The magnetic flux guide part includes magnetic substance parts. The magnetic flux guide part has a structure in which the magnetic substance parts and the insulator parts extend along a direction from the magnetic flux generating part to the heating part and are alternately layered along a circumferential direction of the heating part.

Abstract: The invention pertains to a compound of formula (I), one of its pharmaceutically acceptable salts, or a composition comprising thereof, for use in the prevention or treatment of glucose intolerance related conditions, insulin deficit related conditions, nonalcoholic fatty liver disease and/or obesity.

Abstract: Provided is a curcumin pharmaceutical preparation that is highly water soluble, can maintain the concentration of free curcumin in the blood sufficiently high by being administered parenterally, can effectively obtain a pharmacological action of curcumin, and is highly safe. A pharmaceutical composition for parenteral administration, including a water-soluble substance conjugate of curcumin as an active component.

Abstract: Provided is a transmission device of a single carrier frequency-domain equalization scheme having a circuit in which a cyclic prefix (CP) and an overlap margin (OM) are inserted, and a time-domain windowing processing circuit to which is input a transmission symbol into which the CP and the OM have been inserted. The time-domain windowing processing circuit multiplies an arbitrary time-domain window function and suppresses out-of-band emission. In the time-domain windowing processing circuit, a window transition length of the time-domain window function is equal to or larger than a length of the CP.